Regencell Bioscience Holdings Limited (RGC) NASDAQ

32.54

-11.57(-26.23%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap8.43B
Enterprise Value8.42B
P/E Ratio-4,489.32
PEG Ratio-44.89
Price/Sales Ratio0
Price/Book Ratio3,310.65
Enterprise/Revenue0
Enterprise/EBITDA-4,586.62

Fiscal Year

Fiscal YearJune 30, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.62
Return On Equity-0.62

Income Statement

Revenue0
Revenue/Share0
Gross Profit-392,743
EBITDA-3.19M
Net Income-3.58M
Diluted EPS-0.01

Balance Sheet

Total Cash4.9M
Total Cash/Share0.01
Total Debt544,415
Total Debt/Equity0.11
Current Ratio7.39
Book Value Per Share0.01

Price History

52-Week Change-45.77
52-Week High83.6
52-Week Low0.09
Moving Average 50 Days18.88
Moving Average 200 Days14.91

Statistics

Average Volume386,755
Shares Outstanding494.49M
% Held by Institutions4.87

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor38:1
Last Split DateJune 16, 2025